[1]
|
Altara, R., Ghali, R., Mallat, Z., Cataliotti, A., Booz, G.W. and Zouein, F.A. (2018) Conflicting Vascular and Metabolic Impact of the IL-33/sST2 Axis. Cardiovascular Research, 114, 1578-1594. https://doi.org/10.1093/cvr/cvy166
|
[2]
|
De Vries, M.R. and Quax, P.H. (2016) Plaque Angiogenesis and Its Relation to Inflammation and Atherosclerotic Plaque Destabilization. Current Opinion in Lipidology, 27, 499-506. https://doi.org/10.1097/MOL.0000000000000339
|
[3]
|
Merino-Merino, A., Gonzalez-Bernal, J., Fernandez-Zoppino, D., Saez-Maleta, R. and Perez-Rivera, J.-A. (2021) The Role of Galectin-3 and ST2 in Cardiology: A Short Review. Biomolecules, 11, Article No. 1167.
https://doi.org/10.3390/biom11081167
|
[4]
|
Aimo, A., Migliorini, P., Vergaro, G., Franzini, M., Passino, C., Maisel, A., et al. (2018) The IL-33/ST2 Pathway, Inflammation and Atherosclerosis: Trigger and Target? International Journal of Cardiology, 267, 188-192.
https://doi.org/10.1016/j.ijcard.2018.05.056
|
[5]
|
Schmitz, J., Owyang, A., Oldham, E., Song Y, Murphy, E., McClanahan, T.K., et al. (2005) IL-33, an Interleukin-1-Like Cytokine That Signals via the IL-1 Receptor-Related Protein ST2 and Induces T Helper Type 2-Associated Cytokines. Immunity, 23, 479-490. https://doi.org/10.1016/j.immuni.2005.09.015
|
[6]
|
Vianello, E., Dozio, E., Tacchini, L., Frati, L. and Corsi Romanelli, M.M. (2019) ST2/IL-33 Signaling in Cardiac Fibrosis. The International Journal of Biochemistry & Cell Biology, 116, Article ID: 105619.
https://doi.org/10.1016/j.biocel.2019.105619
|
[7]
|
Cayrol, C. and Girard, J.P. (2018) Interleukin-33 (IL-33): A Nuclear Cytokine from the IL-1 Family. Immunological Reviews, 281, 154-168. https://doi.org/10.1111/imr.12619
|
[8]
|
杨涛, 邓平, 唐嘉宇, 张玲玲. IL_33及其受体ST2与动脉粥样硬化的研究进展[J]. 广州医药, 2015, 46(2): 95-97.
|
[9]
|
Miller, A.M., Xu, D., Asquith, D.L., Denby, L., Li, Y., Sattar, N., et al. (2012) IL-33 Reduces the Development of Atherosclerosis. Journal of Experimental Medicine, 209, 2515. https://doi.org/10.1084/jem.2007186820913c
|
[10]
|
孙爱梅, 刘婷, 陈还珍. 可溶性ST2对冠心病的危险分层价值及其与心功能的关系[J]. 中国心血管杂志, 2017, 22(1): 19-23.
|
[11]
|
Zhang, Y., Fan, Z., Liu, H., Ma, J. and Zhang, M. (2020) Correlation of Plasma Soluble Suppression of Tumorigenicity-2 Level with the Severity and Stability of Coronary Atherosclerosis. Coronary Artery Disease, 31, 628-635.
https://doi.org/10.1097/MCA.0000000000000851
|
[12]
|
Gu, L. and Li, J. (2019) Short-Term and Long-Term Prognostic Value of Circulating Soluble Suppression of Tumorigenicity-2 Concentration in Acute Coronary Syndrome: A Meta-Analysis. Bioscience Reports, 39, BSR20182441.
https://doi.org/10.1042/BSR20182441
|
[13]
|
Liu, X., Hu, Y., Huang, W., Zhang, G., Cao, S., Yan, X., et al. (2019) Soluble ST2 for Prediction of Clinical Outcomes in Patients with ST-Segment Elevation Myocardial Infarction Receiving Primary PCI. International Heart Journal, 60, 19-26. https://doi.org/10.1536/ihj.18-020
|
[14]
|
Mzoughi, K., Chouaieb, S., Zairi, I., Fredj, S., Ben Kilani, M., Berriri, S., et al. (2019) Prognostic Value of ST2 in Myocardial Infarction. Tunisie Medicale, 97, 335-343.
|
[15]
|
陶俊, 戴雯, 周漫, 李艳. 血清可溶性ST2与冠心病患者肾功能的相关性研究[J]. 微循环学杂志, 2021, 31(3): 22-26+31.
|
[16]
|
Lobdell, K.W., Parker, D.M., Likosky, D.S., Rezaee, M., Wyler von Ballmoos, M., Alam, S.S., et al. (2018) Preoperative Serum ST2 Level Predicts Acute Kidney Injury after Adult Cardiac Surgery. Journal of Thoracic and Cardiovascular Surgery, 156, 1114-1123.E2. https://doi.org/10.1016/j.jtcvs.2018.03.149
|
[17]
|
Marino, R., Magrini, L., Orsini, F., Russo, V., Cardelli, P., Salerno, G., et al. (2017) Comparison between Soluble ST2 and High-Sensitivity Troponin I in Predicting Short-Term Mortality for Patients Presenting to the Emergency Department With Chest Pain. Annals of Laboratory Medicine, 37, 137-146. https://doi.org/10.3343/alm.2017.37.2.137
|
[18]
|
李进, 王卫卫. 血清hs-CRP和sST2与急性冠脉综合征患者病情及预后的相关性[J]. 医学临床研究, 2021, 38(5): 713-716.
|
[19]
|
李晓渝, 储岳峰, 周鑫. 急性心肌梗死患者经皮冠状动脉介入治疗后血清sST2、NT-proBNP浓度预测心力衰竭的价值[J]. 岭南心血管病杂志, 2020, 26(2): 138-143.
|
[20]
|
Kercheva, M., Ryabova, T., Gusakova, A., Suslova, T.E., Ryabov, V., Karpov, R.S. (2019) Serum Soluble ST2 and Adverse Left Ventricular Remodeling in Patients with ST-Segment Elevation Myocardial Infarction. Clinical Medicine Insights, 13, Article ID: 1179546819842804. https://doi.org/10.1177/1179546819842804
|
[21]
|
Miñana, G., Núñez, J., Bayés-Genís, A., Revuelta-López, E., Ríos-Navarro, C., Núñez, E., et al. (2018) ST2 and Left Ventricular Remodeling after ST-Segment Elevation Myocardial Infarction: A Cardiac Magnetic Resonance Study. International Journal of Cardiology, 270, 336-342. https://doi.org/10.1016/j.ijcard.2018.06.073
|
[22]
|
Aleksova, A., Paldino, A., Beltrami, A.P., Padoan, L., Iacoviello, M., Sinagra, G., et al. (2019) Cardiac Biomarkers in the Emergency Department: The Role of Soluble ST2 (sST2) in Acute Heart Failure and Acute Coronary Syndrome-There is Meat on the Bone. Journal of Clinical Medicine, 8, Article No. 270.
https://doi.org/10.3390/jcm8020270
|
[23]
|
Martínez-Martínez, E., Cachofeiro, V., Rousseau, E., Álvarez, V., Calvier, L., Fernández-Celis, A., et al. (2015) Interleukin-33/ST2 System Attenuates Aldosterone-Induced Adipogenesis and inflammation. Molecular and Cellular Endocrinology, 411, 20-27. https://doi.org/10.1016/j.mce.2015.04.007
|
[24]
|
Chen, B., Geng, J., Gao, S.X., Yue, W.W. and Liu, Q. (2018) Eplerenone Modulates Interleukin-33/sST2 Signaling and IL-1beta in Left Ventricular Systolic Dysfunction after Acute Myocardial Infarction. Journal of Interferon & Cytokine Research, 38, 137-144. https://doi.org/10.1089/jir.2017.0067
|
[25]
|
Xia, J., Qu, Y., Yin, C. and Xu, D. (2017) Preliminary Study of Beta-Blocker Therapy on Modulation of Interleukin-33/ST2 Signaling during Ventricular Remodeling after Acute Myocardial Infarction. Cardiology Journal, 24, 188-194. https://doi.org/10.5603/CJ.a2016.0096
|
[26]
|
Feng, Q., Lu, C., Wang, L., Song, L., Li, C. and Uppada, R.C. (2017) Effects of Renal Denervation on Cardiac Oxidative Stress and Local Activity of the Sympathetic Nervous System and Renin-Angiotensin System in Acute Myocardial Infracted Dogs. BMC Cardiovascular Disorders, 17, Article No. 65. https://doi.org/10.1186/s12872-017-0498-1
|
[27]
|
Sharp 3rd, T.E. and Lefer, D.J. (2021) Renal Denervation to Treat Heart Failure. Annual Review of Physiology, 83, 39-58. https://doi.org/10.1146/annurev-physiol-031620-093431
|
[28]
|
Zhao, Y.N., Li, H., Zhao, C. and Liu, G.-H. (2020) ST2 Silencing Aggravates Ventricular Remodeling and Chronic Heart Failure in Rats by Mediating the IL-33/ST2 Axis. Journal of Tissue Engineering and Regenerative Medicine, 14, 1201-1212. https://doi.org/10.1002/term.3091
|
[29]
|
Díez, J. and Bayes-Genis, A. (2017) Compelling Benefit of Soluble Suppression of Tumorigenicity-2 in Post-Myocardial Infarction Estimation of Risk: The Time Is Right for Its Routine Use in the Clinic. Journal of the American Heart Association, 6, e007665. https://doi.org/10.1161/JAHA.117.007665
|